Home/Filings/4/0001847903-25-000108
4//SEC Filing

Hedley Mary Lynne 4

Accession 0001847903-25-000108

CIK 0001847903other

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 4:13 PM ET

Size

5.8 KB

Accession

0001847903-25-000108

Insider Transaction Report

Form 4
Period: 2025-06-20
Transactions
  • Award

    Share Option (right to buy)

    2025-06-20+40,00040,000 total
    Exercise: $12.43Exp: 2035-06-20Ordinary Shares (40,000 underlying)
Footnotes (2)
  • [F1]The shares subject to such option will vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of shareholders, subject to continued service as a director through the applicable vesting date.
  • [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Issuer

Centessa Pharmaceuticals plc

CIK 0001847903

Entity typeother

Related Parties

1
  • filerCIK 0001340823

Filing Metadata

Form type
4
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:13 PM ET
Size
5.8 KB